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A history of early life adversity (ELA) has health-related consequences that persist beyond
the initial maltreatment and into adulthood. Childhood adversity is associated with abnor-
mal glucocorticoid signaling within the hypothalamic-pituitary-adrenal (HPA) axis and the
development of functional pain disorders such as the irritable bowel syndrome (IBS). IBS
and many adult psychopathologies are more frequently diagnosed in women, and ovarian
hormones have been shown tomodulate pain sensitivity.Therefore, the sexually dimorphic
effects of ELA and the role of ovarian hormones in visceral pain perception represent critical
research concepts to enhance our understanding of the etiology of IBS. In this review, we
discuss current animal models of ELA and the potential mechanisms through which ovar-
ian hormones modulate the HPA axis to alter nociceptive signaling pathways and induce
functionally relevant changes in pain behaviors following ELA.
Keywords: early life stress, neonatal stress, visceral pain, HPA, sex differences, glucocorticoid
INTRODUCTION
Early life adversity (ELA) including parental neglect, chronic phys-
ical abuse, sexual abuse, and social stress profoundly affects brain
development and increases the risk for adult psychopathologies.
ELA is common with nearly 40% of Americans reporting expo-
sure to a traumatic event prior to 13 years of age, and represents
a substantial public health burden (Koenen et al., 2010). A pos-
itive correlation has been observed between ELA and comorbid
pathophysiological, behavioral, and social problems in adulthood,
suggesting that the effects of ELA are pervasive across a broad
spectrum of adult disorders (Anda et al., 2006). Furthermore,
childhood abuse increases the likelihood of adult gastrointestinal
(GI) disorders such as irritable bowel syndrome (IBS), a prevalent
functional GI disorder which affects 15–20% of the population
and is characterized by chronic abdominal pain due to increased
awareness of visceral stimuli and abnormal bowel habits (White-
head et al., 1990; Talley et al., 1991). In a recent clinical study, IBS
patients were two to four times more likely to report a history of
ELA compared to healthy control subjects (Bradford et al., 2012).
Importantly, psychosocial factors, such as a history of childhood
abuse, are thought to elicit abnormal bidirectional communica-
tion along the brain-gut axis to influence IBS symptomatology
(Ringel and Drossman, 2002; Camilleri, 2004). To date, the precise
mechanisms by which ELA induces visceral hypersensitivity and
abnormal pain reporting remain to be determined.
Dysregulation of the hypothalamic-pituitary-adrenal (HPA)
axis is often observed in patients previously exposed to child-
hood abuse and is commonly reported in IBS patients (Dinan
et al., 2006; Tarullo and Gunnar, 2006; Chang et al., 2009). Specifi-
cally, abnormal functioning of the amygdala, an important limbic
structure involved in the facilitation of the HPA axis has been
observed in IBS patients and in adults following childhood trauma
(Bonaz et al., 2002; Naliboff et al., 2003; Wilder-Smith et al., 2004;
Tottenham et al., 2010). Abnormal glucocorticoid (GR) receptor
signaling throughout the HPA axis is observed following ELA and
in IBS patients (Dinan et al., 2006; Wilkinson and Goodyer, 2011).
Therefore, it is likely that aberrant functioning of the HPA axis
contributes to IBS symptomatology in response to ELA.
Although ELA increases the risk of persistent disorders later
in life for both men and women, evidence suggests that females
are more susceptible to the effects of ELA and the development
of adult pathologies (Hyman et al., 2008; Fisher et al., 2009; Xie
et al., 2012). Female IBS patients were more likely to report ELA
than healthy controls, whereas ELA history was similar between
male IBS patients and controls, suggesting that women are more
vulnerable to the enduring effects of ELA on the development of
functional abdominal pain in adulthood (Bradford et al., 2012).
Clinical data have shown that functional pain disorders including
IBS, chronic pelvic pain, and painful bladder syndrome are more
common in women, suggesting a sexually dimorphic pathophysi-
ology of these disorders (Berkley, 1997; Lee et al., 2001). Although
the precise mechanisms which contribute to the female predomi-
nance of these functional pain disorders are unknown, imaging
studies revealed gender differences in regional brain responses
to visceral stimuli, specifically showing greater amygdala acti-
vation following rectal distension in women compared to men
(Berman et al., 2000). In addition to unique patterns of brain
activation, the sex-related bias of these disorders, particularly fol-
lowing ELA, suggest that ovarian hormones play a prominent role
in visceral hypersensitivity. Indeed, previous evidence illustrates
that sex differences in pain sensitivity are influenced by cyclical
changes in ovarian hormones (Hellstrom and Anderberg, 2003).
Specifically, symptom exacerbation and increased rectal sensitiv-
ity are observed in female IBS patients during menses, and pain
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sensitivity and perceived stress are also increased during high cycli-
cal levels of estrogen and progesterone in fibromyalgia patients
(Heitkemper et al., 1995; Kane et al., 1998; Korszun et al., 2000;
Houghton et al., 2002). These studies strongly support that cir-
culating ovarian hormones modulate pain behavior; however the
precise mechanisms have yet to be elucidated.
Due to the difficulty of controlling for confounding factors
within the clinical population and ethical limitations, a system-
atic investigation of the mechanisms responsible for enhanced
adult pathologies following childhood adversity is very difficult in
human subjects. Therefore, rodent models of ELA have provided
considerable insight into the persistent effects of early life mal-
treatment on pain and behavior (Barreau et al., 2007). Although
sex-related biases have been reported clinically, rodent models of
adult psychopathologies and pain disorders are predominantly
performed in male rats. This is particularly true when investigating
the long-term impact of ELA on adult behavior and working exclu-
sively with males allows for a less complex experimental design
and fewer complications with animal housing. Therefore, very lit-
tle is known about the role of ovarian hormones in these adult
syndromes, specifically in the context of ELA.
This review summarizes the recent literature on the effect of
ELA on abnormal pain perception with a particular focus on sex
differences. In this review, we discuss the potential mechanisms
of increased pain following ELA and focus on the role of ovar-
ian hormones and HPA-mediated mechanisms. In addition, we
discuss the central processes involved in persistent abnormali-
ties of pain perception and anxiety following ELA and highlight
specific structures involved in the pain perception including the
hippocampus and amygdala. Together, this review provides an
important summary of important findings and suggests poten-
tial areas that may represent useful therapeutic targets for the
treatment of pain disorders, such as IBS following ELA.
RELEVANT ANIMAL MODELS OF ELA
The most documented model of ELA is maternal separation
(MS), which consists of removing pups from the nest, mother,
and home cage for varying periods of time during the early
postnatal period (PN2–14; Plotsky and Meaney, 1993). MS has
differential effects in adulthood that depend on the duration of
separation and the specific number of separation days, which
largely appear due to altered maternal behavior upon the pups
return to the nest. For instance, a brief separation of 15 min
per day from PN2 to PN14 results in increased maternal atten-
tion upon return of the litter (heightened licking and grooming
and increased arched-back nursing) that causes decreased reac-
tivity of the HPA axis in response to stress of the offspring in
adulthood (Levine, 1967; Plotsky and Meaney, 1993). However,
more substantial MS (3 h from PN2 to PN14) decreased lick-
ing and grooming and arched-back nursing (LG-ABN) by the
mother and caused hyper-reactivity of the HPA axis in adult-
hood. In addition to the changes in HPA activation, differential
effects on visceral sensitivity are observed depending on the MS
paradigm. Separation for 3-h per day induced visceral hypersensi-
tivity quantified as an exaggerated visceromotor response (VMR)
to colorectal distension (CRD) and at baseline and following
acute stress as compared to non-handled and handled (15 min
MS) controls (Coutinho et al., 2002). Furthermore, MS reduces
opioid-mediated nociceptive inhibition of visceral pain responses
in adulthood (Coutinho et al., 2002). Therefore, MS represents a
simple and easily reproducible model of ELA that mimics the clin-
ical situation of altered HPA activity and visceral hypersensitivity
in adulthood.
Another model of ELA that is becoming more widely used is the
model of limiting the available nesting material (Gilles et al., 1996).
In this model, rat mothers and pups are housed in a wire-bottom
cage and given a single sheet of paper towel as nesting material
from PN2 to PN9. The limited nesting model induces sporadic,
fragmented, and unpredictable maternal behavior during the ELA
period (Ivy et al., 2008). These maternal behaviors are consistent
with those observed in the MS paradigm; however the limited
nesting model has the unique advantage of inducing abnormal
maternal care without separating the dam from her pups. In the
clinical situation of neglect and abuse, the mother is generally
present but exhibits improper and abnormal care (Whipple and
Webster-Stratton, 1991; Kendall-Tackett, 2007). Therefore, lim-
ited nesting is a clinically relevant model of ELA, which has been
shown to affect the HPA-responsiveness of pups and alter noci-
ceptive sensitivity in adulthood (Avishai-Eliner et al., 2001; Green
et al., 2011).
A third model of ELA relies on neonatal colonic irritation (nCI)
via either colonic infusion of mustard oil or repeated CRD during
the early neonatal period (Al-Chaer et al., 2000). Although this
model of ELA relies on colonic manipulation, no overt or histo-
logical changes are observed to the colonic mucosa in adulthood.
nCI has been shown to cause visceral hypersensitivity charac-
terized by increased neuronal excitability along with changes in
ionic conductance across the colonic mucosa in adulthood (Al-
Chaer et al., 2000; Lin and Al-Chaer, 2003, 2005; Chaloner et al.,
2010). Neonatal pain has been shown to induce neurogenesis;
therefore, visceral hypersensitivity following nCI may result from
enhanced neurogenesis directly in primary pain processing areas
(Leslie et al., 2011). Furthermore, nCI increases spinal neuronal
excitability and induces thoracolumbar and lumbosacral visceral
afferent sensitization (Al-Chaer et al., 2000; Lin and Al-Chaer,
2003).
Models of ELA often mimic the clinical situation of psychologi-
cal trauma and neglect, while ignoring ELA resulting from abusive
relationships, which is an important contributor to the develop-
ment of adult pathologies such as IBS (Bryer et al., 1987; Bradford
et al., 2012). In addition, previous studies suggest that classical con-
ditioning in response to previous experience with painful stimuli
may contribute to increased pain sensitivity, particularly in IBS
patients (Lembo et al., 1999; Nozu et al., 2006). Additionally, pas-
sage of hard stool in infancy causes intense pain and conditions
the child to avoid defecation, which may contribute the devel-
opment of altered bowel habits and chronic abdominal pain in
adulthood (Al-Chaer and Hyman, 2007). Therefore, a condition-
ing model of ELA is consistent with human circumstances related
to heightened pain and anxiety in adulthood; however most mod-
els of ELA lack a conditioning component. The animal model
of ELA used in our laboratory utilizes neonatal Pavlovian con-
ditioning and is particularly relevant to the understanding the
mechanisms of IBS. This model, which has been well developed
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and characterized by Sullivan et al. (2000) relies on conditioned
responses to an odor stimulus, and closely mimics the human sit-
uation of attachment to an abusive caregiver (Haroutunian and
Campbell, 1979; Camp and Rudy, 1988). A conditioning model of
ELA has an additional advantage that allows for control of shock
predictability based on the presence or absence of an odor cue
(Tyler et al., 2007). In this paradigm, paired odor-shock serves as
a model of predictable adversity, whereas unpaired odor-shock is
a model for unpredictable ELA. Using this model of ELA, we have
shown that only unpaired (or unpredictable) infant experiences
result in the development of visceral hypersensitivity and abdomi-
nal pain in adult rats as demonstrated by an increase in the number
of abdominal contractions in response to nociceptive CRD (Tyler
et al., 2007). This indicates that the predictability of ELA is impor-
tant such that only unpredictable neonatal experiences will result
in the development of visceral pain in adulthood. Additionally,
through measurements in a light-dark box, which utilizes a rat’s
avoidance of bright spaces compared to dark areas to assess anxiety,
we have shown that animals receiving unpredictable ELA demon-
strate an increase in anxiety as compared to paired and odor-only
animals in adulthood (Tyler et al., 2007). These data suggest that
a neonatal conditioning model of ELA accurately reproduces vis-
ceral hypersensitivity and altered anxiety-like behavior, which is
consistent with the clinical setting of IBS (Whitehead et al., 1990,
2002).
ROLE OF OVARIAN HORMONES IN PAIN AND BEHAVIOR
Sex differences in nociception have been reported clinically and
observed in rodent models, and sex differences in regional brain
activation in response to CRD are similar between rodents and
human studies (Ji et al., 2006; Wang et al., 2009). Cyclical changes
in pain sensitivity have been detected across the menstrual cycle
and have also been observed in the rodent estrus cycle, with the
greatest visceral sensitivity to luminal distension observed dur-
ing proestrus, a phase characterized by heightened estradiol and
progesterone (Sapsed-Byrne et al., 1996; Ji et al., 2008). Previous
studies in rodent models have shown that females are more suscep-
tible to developing visceral hypersensitivity following exposure to
MS or odor-shock conditioning (Rosztoczy et al., 2003; Chaloner
and Greenwood-Van Meerveld, 2013). These data provide support
that ovarian hormones play a prominent role in maintaining the
persistent effects of ELA on increased pain sensitivity in humans
and rodent models. However, the mechanisms by which ovarian
hormones modulate visceral sensitivity are poorly understood.
Ovarian hormones are important modulators of brain plas-
ticity and organization (Fitch and Denenberg, 1998). The effects
of ovarian hormones on physiological functions can be classified
according to two broad categories: organizational and activational
(McCarthy, 2008). The organizational effects of sex hormones
generally occur during development and are established follow-
ing initial exposure in the perinatal period; however evidence
also suggests that central organizational effects may occur dur-
ing puberty or late adulthood, effectively establishing the tone for
the future fluctuations of ovarian hormones (Rodriguez-Sierra,
1986; McCarthy, 2008). The activational effects occur when sex
hormones are present and readily available to act on their respec-
tive targets. These activational effects are thought to be mediated
via the neuronal circuits that were established during the peri-
natal organizational period. However, the relative role of orga-
nizational vs. activational effects of ovarian hormones on adult
pathologies following ELA has not been adequately studied. Data
from our laboratory have shown that effectively abolishing the
activational role of ovarian hormones via ovariectomy (OVX)
reverses the effects of ELA on adult visceral pain hypersensi-
tivity in female rats (Chaloner and Greenwood-Van Meerveld,
2013). Furthermore, reintroduction of ovarian hormones via a
subcutaneous estradiol pellet was sufficient to induce visceral
hyperalgesia to nociceptive CRD (Chaloner and Greenwood-
Van Meerveld, 2013). Clinical evidence confirms that the activa-
tional effects of ovarian hormones play a direct role in visceral
pain modulation. Previously, Mathias et al. (1994a,b) demon-
strated that pharmacological OVX via leuprolide acetate treatment
dramatically diminishes IBS-like symptomatology in female. In
addition, pain sensitivity is reduced in female IBS patients fol-
lowing menopause (Palsson et al., 2003), showing a direct role
for the activational effects of ovarian hormones in modulating
visceral pain. The effects of hormonal changes during preg-
nancy on visceral pain have been difficult to quantify due to
the similarity in frequently reported complaints of pregnancy
and IBS symptomatology (i.e., nausea, abdominal pain, consti-
pation, and diarrhea), and require further investigation (Bruno,
2004).
An important ovarian hormone that directly modulates pain
perception in clinical studies and animal models is estradiol or
estrogen. Estrogens can act as neurosteroids to increase glutamate-
mediated excitation, reduce GABAergic inhibition, increase hip-
pocampal c-Fos expression, and potentiate synaptic plasticity,
effectively increasing neuronal excitability throughout the cen-
tral nervous system (CNS; Aloisi and Bonifazi, 2006). This
increased neuronal excitability may drive heightened nocicep-
tion in females, which is observed during periods of high estro-
gens. Indeed, fibromyalgia symptomatology is highest in women
when estrogen is highest in the luteal phase of the menstrual
cycle (Korszun et al., 2000). Estradiol and progesterone have
been shown to directly modulate somatic pain behavior in rats
(Kayser et al., 1996). In addition, estradiol implanted directly
onto the central nucleus of the amygdala (CeA) was shown to
increase visceral sensitivity to CRD in a rodent model (Myers
et al., 2011). The role of estradiol in nociception can also be
observed in males. For instance, intracerebroventricular (i.c.v.)
estradiol has been shown to increase licking following subcu-
taneous formalin injection in male rats, and estradiol local-
ized to the amygdala increased visceral pain behavior in males
(Aloisi and Ceccarelli, 2000; Myers et al., 2011). These data
highlight the importance of estradiol in nociception and pain
behavior.
ELA AND THE STRESS AXIS
During early neonatal development rat pups exhibit low basal
levels of the stress hormone corticosterone (CORT; cortisol in
humans), and reduced activation of the HPA axis in response to
stress. This stage of reduced HPA activation, which occurs during
the first 2 weeks of life in the rat, is known as the stress hypore-
sponsive period (SHRP) and represents a critical time for the
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development of a normal stress axis (Meaney and Aitken, 1985;
De Kloet et al., 1988). In rodents, the SHRP is maintained by
appropriate interactions in the mother-pup relationship, which
relies heavily on arched-backed nursing and appropriate lick-
ing and grooming behaviors (Levine, 1994; Aisa et al., 2008).
Quiescence of the HPA axis during the SHRP is crucial for the
development of a normal stress response. Disruptions in mother-
pup interactions, as in the limited nesting or MS models, lead to
the development of a premature adult-like stress response, and
potentially cause permanent changes in adult HPA functional-
ity (Plotsky et al., 2005). Normally, stress causes the release of
corticotrophin-releasing factor (CRF) from the parvocellular cells
of the paraventricular nucleus of the hypothalamus (PVN) into
the hypophyseal portal system. CRF then acts on the anterior
pituitary gland to signal the release of adrenocorticotrophic hor-
mone (ACTH), which enters systemic circulation to interact with
the adrenal cortex and ultimately results in the release of CORT.
CORT then acts on the hippocampus, PVN, and pituitary to acti-
vate a negative feedback mechanism and shut down further HPA
activation (De Kloet and Reul, 1987; Ladd et al., 2004). In the brain,
CORT mediates its actions via GR and mineralocorticoid receptors
(MR), which have distinct distribution and function throughout
the CNS. Receptor binding studies indicate that MR has a 10-
fold greater affinity for CORT than GR; therefore, when CORT
is low, such as at basal levels, the observed effects are mediated
through MR. Under stressful conditions, MR becomes saturated,
and CORT is free to act on GR to induce the negative feedback
mechanisms of the HPA axis (Francis et al., 1999; Weaver et al.,
2004). Although little is known about the effects of ELA on MR,
ELA has been shown to significantly alter GR expression and the
functioning of the HPA axis in clinical studies and animal mod-
els. For example, prolonged MS increases CRF mRNA density in
the PVN and decreases GR expression in the hippocampus (Ladd
et al., 2004; Aisa et al., 2008). Reduced hippocampal GR may
contribute to allostatic overload or a deficiency in the negative
feedback mechanisms of the HPA axis which allows for hyper-
activation in adulthood. Indeed, exposure to ELA results in an
overactive HPA axis with increased ACTH peak and prolonged
elevated CORT levels in response to air puff startle (Plotsky et al.,
2005). Meaney and colleagues have further advanced these obser-
vations in a model which utilizes naturally occurring variations
in maternal behavior to separate “good moms” and “bad moms”
based on high vs. low LG-ABN, respectively. Their results have pro-
vided intriguing data on reduced negative feedback mechanisms
in the HPA axis following poor maternal care. In their studies, low
LG-ABN mothers produce offspring with reduced expression of
hippocampal GR (Liu et al., 1997; Francis et al., 1999). Through the
use of cross-fostering, decreased hippocampal GR has been shown
to be an effect of environment, rather than due to heritable changes
in behavior (Francis et al., 1999). Furthermore, the reduction in
GR in low LG-ABN offspring is maintained into adulthood as a
direct result of epigenetic modification through enhanced methy-
lation of exon 17, the GR promoter region, which inhibits binding
of nerve growth factor-inducible protein A, a transcriptional acti-
vator GR (Weaver et al., 2004). These data provide support that
subtle changes in maternal behavior, whether naturally occurring
or induced via MS or limited nesting, can alter the functioning of
the HPA axis and result in reduced negative feedback of the system,
contributing to stress-related pathologies in adulthood.
OVARIAN HORMONES AND THE HPA AXIS
Women are more vulnerable to develop anxiety disorders follow-
ing traumatic events, suggesting a role for ovarian hormones in
influencing the HPA axis activation (Yonkers and Ellison, 1996;
Seeman, 1997; Isgor et al., 2003). In rodent models, females exhibit
greater ACTH and CORT release in response to stress as compared
to males, and a direct correlation between ovarian hormones and
HPA activation has been shown where plasma and adrenal CORT
levels are the highest during the proestrus phase, a period of the
estrous cycle characterized by elevated serum estradiol (Raps et al.,
1971; Handa et al., 1994). These data suggest that high levels of
estradiol and progesterone increase activation of the HPA axis. A
direct relationship between estradiol and HPA activation has been
shown in a recent study where i.c.v. administration and infusion of
estradiol to the PVN caused a significant increase in CORT, show-
ing that central estradiol has profound effects on the HPA axis (Liu
et al., 2012). The actions of estradiol or estrogen within the brain
are mediated via two types of receptors, estrogen receptor alpha
(ERα) and ERβ, which have distinct distribution and functions
within the CNS. Previous results have implicated an important
role of ERα in the regulation of the HPA axis. Estradiol and propy-
lpyrazole triol, an ERα agonist, significantly increased the CORT
response to a 30 min restraint stressor when directly infused onto
the PVN, whereas the ER antagonist ICI 183,780 reduced stress-
induced CORT release (Liu et al., 2012). ERα agonist treatment in
OVX rats increased CORT and ACTH levels in response to stress,
increased activation of the PVN, and impaired dexamethasone-
induced suppression of CORT release (Weiser and Handa, 2009).
These data suggest that estradiol, acting through central ERα,
reduces negative feedback mechanisms of the HPA axis, similar
to what was previously described following ELA. Furthermore,
estradiol may mediate its effects on HPA activation through tran-
scriptional regulation of specific gene targets, which are impor-
tant mediators of the HPA axis (Kageyama and Suda, 2009).
Estrogen response elements (EREs) have been observed in the
CRF gene promoter region and estradiol and diarylpropionitrile
(DPN), an ERβ selective agonist, directly increased CRF expres-
sion in hypothalamic 4B cells (Vamvakopoulos and Chrousos,
1993; Ogura et al., 2008). In addition, high estradiol replacement
increased basal hypothalamic CRF and elevated plasma CORT
and ACTH in OVX rats, which provides functionally relevant evi-
dence that estradiol regulates CRF expression in vivo (Ochedalski
et al., 2007). Estradiol-mediated regulation of GR transcription
has also been found in breast cancer cell lines. These studies have
shown that estradiol treatment significantly reduces GR expression
and increases protein phosphatase 5 activity, which dephospho-
rylates and subsequently inactivates GR (Krishnan et al., 2001;
Zhang et al., 2009). Additionally, ER activation has been shown
to target GR for proteosomal degradation and reduce GR protein
expression (Kinyamu and Archer, 2003). The combined action
of estradiol through ERα-mediated action, direct transcriptional
alterations, and post-translational regulation reduces the nega-
tive feedback of the HPA axis by decreasing GR and increasing
CRF-mediated signaling.
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EVIDENCE TO SUPPORT ABNORMALITIES IN AMYGDALA
ACTIVITY IN RESPONSE TO ELA
In addition to the changes observed in the hippocampus, previ-
ous studies suggest that ELA alters other key brain areas involved
in programming of the HPA axis including the amygdala and
the locus coeruleus (LC; Liu et al., 1997; Caldji et al., 1998;
Sevelinges et al., 2007; McGowan et al., 2009). While the effect
of elevated CORT in the brain and periphery is inhibitory as a
component of the negative feedback on the HPA axis within the
PVN and hippocampus, CORT acting at the level of the amyg-
dala serves to facilitate the HPA axis. Exposure to ELA causes
abnormal amygdala development and increases CRF expression
within the amygdala, which may cause persistent abnormali-
ties and enhanced facilitation of the HPA axis (Cratty et al.,
1995; Hatalski et al., 1998; Vazquez et al., 2006; Becker et al.,
2007). Additional studies using MS have further characterized
this altered expression by showing sexually dimorphic changes
in CRF immunoreactivity within the CeA following ELA (Des-
bonnet et al., 2008). Furthermore, exposure to adverse care
from infancy to early and late childhood significantly increases
amygdala volume and enhances amygdala activity in the clin-
ical population (Mehta et al., 2009; Tottenham et al., 2010).
Although the mechanism by which ELA alters amygdala activ-
ity is unclear, data suggest that aberrant amygdala function-
ing following ELA results in enhanced CRF release to facilitate
the stress response, which may contribute to increased anxi-
ety (Hatalski et al., 1998; Becker et al., 2007). The amygdala
has also been shown to be an important structure involved in
the modulation of pain, and may be particularly relevant to
enhanced visceral pain in IBS (Berman et al., 2000; Naliboff et al.,
2003; Neugebauer et al., 2004). Data from our laboratory have
highlighted the importance of CORT acting at the level of the
amygdala to increase visceral pain behavior in a rodent model
(Greenwood-Van Meerveld et al., 2001; Myers and Greenwood-
Van Meerveld, 2007, 2010, 2012). The precise mechanism by
which amygdala activation induces heightened visceral sensitiv-
ity is unknown; however, the amygdala has diffuse connections
to important brain nuclei involved in pain modulation including
the hypothalamus, LC, Barrington’s nucleus, dorsal motor nucleus
of the vagus, nucleus of the solitary tract, the raphe nucleus,
periaqueductal gray, and the parabrachial nucleus (Myers and
Greenwood-Van Meerveld, 2009). Therefore, hyperactivation of
the amygdala may serve to increase not only HPA activity but
also contribute to enhanced visceral pain perception following
ELA.
CONCLUDING REMARKS
Visceral pain is the hallmark feature of IBS, a prominent GI
disorder with a substantial socioeconomic burden of approxi-
mately $1.7 billion a year in direct costs. However the etiology
and mechanisms of IBS are poorly understood and efficient ther-
apeutic interventions have yet to be developed (Hulisz, 2004). A
relationship between ELA and the development of IBS in adult-
hood has been described in clinical literature and animal models.
Furthermore, both ELA and IBS are characterized by female pre-
dominance and dysregulation of the HPA axis (Drossman et al.,
1997; Whitehead et al., 2002; Dinan et al., 2006; Tarullo and Gun-
nar, 2006; Hyman et al., 2008; Chang et al., 2009). Therefore, the
mechanisms by which ELA induces visceral hypersensitivity likely
involve ovarian hormones and signaling within the HPA axis. In
this review, we discussed previous research in rodent models that
demonstrated increased visceral pain behaviors following ELA and
the advantages and disadvantages of relevant models of ELA. Data
from rodent literature suggests that ELA directly influences noci-
ception and alters signaling in the HPA axis, with specific changes
in amygdala-mediated mechanisms. Therefore, it is our hypothe-
sis that ELA sets the stage to increase pain sensitivity and enhance
the responsiveness of the HPA axis, either through reduced neg-
ative feedback or increased facilitation. Following maturity, the
activational effects of ovarian hormones act to further increase
this priming and ultimately contribute to the development of
adult disorders such as IBS, fibromyalgia, and heightened anxi-
ety. Therefore, ELA may serve as a predisposing factor, which can
be further potentiated due to the effects of ovarian hormones to
increase activation of pain pathways and the HPA axis, explaining
the increased incidence of these disorders in women.
The importance of sex hormones and HPA signaling through
CRF and GRs, particularly following ELA, may have a critical
influence on the understanding of the pathophysiology and mech-
anisms of IBS. The data highlighted within this review strongly
suggest that ovarian hormones, specifically estradiol, may be
important modulators of the effects of ELA on visceral pain per-
ception and HPA activation. Understanding these sexually dimor-
phic mechanisms of disease may lead to the development of more
targeted and specific therapies which could have profound effects
on management of visceral pain as seen in functional disorders
such as IBS, where a clear etiology has not yet been identified.
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